510(k) K772250
K772250 is an FDA 510(k) premarket notification submitted by Kallestad Laboratories, Inc. for the device "ALPHA-1-ANTITRYPSIN NEPHEL. ASSAY". The FDA issued a decision of Substantially Equivalent on December 22, 1977. The device falls under product code DEI (Alpha-1-Antitrypsin, Fitc, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5130. Kallestad Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 22, 1977
- Date Received
- December 9, 1977
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Alpha-1-Antitrypsin, Fitc, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5130
- Review Panel
- IM
- Submission Type